Downregulation of the cAMP/PKA pathway in PC12 cells overexpressing NCS-1
Bruno R Souza1, Karen C L Torres, Débora M Miranda
1Departamento de Saúde Mental, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. brunorezendesouza@gmail.com
Abstract:
It is well known that dopamine imbalances are associated with many psychiatric disorders and that the dopaminergic receptor D₂ is the main target of antipsychotics. Recently it was shown that levels of two proteins implicated in dopaminergic signaling, Neuronal calcium sensor-1 (NCS-1) and DARPP-32, are altered in the prefrontal cortex (PFC) of both schizophrenic and bipolar disorder patients. NCS-1, which inhibits D₂ internalization, is upregulated in the PFC of both patients. DARPP-32, which is a downstream effector of dopamine signaling, integrates the pathways of several neurotransmitters and is downregulated in the PFC of both patients. Here, we used PC12 cells stably overexpressing NCS-1 (PC12-NCS-1 cells) to address the function of this protein in DARPP-32 signaling pathway in vitro. PC12-NCS-1 cells displayed downregulation of the cAMP/PKA pathway, with decreased levels of cAMP and phosphorylation of CREB at Ser133. We also observed decreased levels of total and phosphorylated DARPP-32 at Thr34. However, these cells did not show alterations in the levels of D₂ and phosphorylation of DARPP-32 at Thr75. These results indicate that NCS-1 modulates PKA/cAMP signaling pathway. Identification of the cellular mechanisms linking NCS-1 and DARPP-32 may help in the understanding the signaling machinery with potential to be turned into targets for the treatment of schizophrenia and other debilitating psychiatric disorders.
Insights
Neuronal calcium sensor-1 (NCS-1) upregulation in the brain alters dopamine signaling by downregulating the cAMP/PKA pathway and DARPP-32. This finding may inform treatments for psychiatric disorders like schizophrenia.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatric Research
Background:
- Dopamine pathway dysregulation is linked to psychiatric disorders.
- Neuronal calcium sensor-1 (NCS-1) and DARPP-32 are implicated in dopaminergic signaling and altered in schizophrenia and bipolar disorder.
- NCS-1 inhibits D₂ receptor internalization and is upregulated, while DARPP-32 is downregulated in patient prefrontal cortex.
Purpose of the Study:
- To investigate the in vitro function of NCS-1 in the DARPP-32 signaling pathway.
- To elucidate the cellular mechanisms linking NCS-1 and DARPP-32.
Main Methods:
- Utilized PC12 cells stably overexpressing NCS-1 (PC12-NCS-1 cells).
- Assessed levels of cAMP, phosphorylated CREB, and total and phosphorylated DARPP-32 (at Thr34 and Thr75).
- Examined levels of dopaminergic receptor D₂.
Main Results:
- PC12-NCS-1 cells showed downregulation of the cAMP/PKA pathway, with decreased cAMP and CREB phosphorylation.
- Total and phosphorylated DARPP-32 levels (at Thr34) were decreased in PC12-NCS-1 cells.
- No significant alterations were observed in D₂ receptor levels or DARPP-32 phosphorylation at Thr75.
Conclusions:
- NCS-1 modulates the PKA/cAMP signaling pathway.
- Understanding the NCS-1 and DARPP-32 link offers potential therapeutic targets for psychiatric disorders.
- Further research into these cellular mechanisms could advance treatments for schizophrenia and bipolar disorder.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades

